JP2002512988A5 - - Google Patents

Download PDF

Info

Publication number
JP2002512988A5
JP2002512988A5 JP2000545583A JP2000545583A JP2002512988A5 JP 2002512988 A5 JP2002512988 A5 JP 2002512988A5 JP 2000545583 A JP2000545583 A JP 2000545583A JP 2000545583 A JP2000545583 A JP 2000545583A JP 2002512988 A5 JP2002512988 A5 JP 2002512988A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
lhrh antagonist
lhrh
formulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000545583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002512988A (ja
Filing date
Publication date
Priority claimed from US09/067,327 external-priority patent/US6217844B1/en
Application filed filed Critical
Publication of JP2002512988A publication Critical patent/JP2002512988A/ja
Publication of JP2002512988A5 publication Critical patent/JP2002512988A5/ja
Withdrawn legal-status Critical Current

Links

JP2000545583A 1998-04-27 1999-04-27 Ｌｈｒｈアンタゴニストを使用して密度の高い乳房組織中の病変を検出するための方法 Withdrawn JP2002512988A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/067,327 1998-04-27
US09/067,327 US6217844B1 (en) 1998-04-27 1998-04-27 Methods for detecting lesions in dense breast tissue using LHRH antagonists
PCT/US1999/009082 WO1999055387A1 (en) 1998-04-27 1999-04-27 Methods for detecting lesions in dense breast tissue using lhrh antagonists

Publications (2)

Publication Number Publication Date
JP2002512988A JP2002512988A (ja) 2002-05-08
JP2002512988A5 true JP2002512988A5 (https=) 2006-06-08

Family

ID=22075262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000545583A Withdrawn JP2002512988A (ja) 1998-04-27 1999-04-27 Ｌｈｒｈアンタゴニストを使用して密度の高い乳房組織中の病変を検出するための方法

Country Status (9)

Country Link
US (3) US6217844B1 (https=)
EP (1) EP1073477A4 (https=)
JP (1) JP2002512988A (https=)
KR (1) KR20010098364A (https=)
CN (1) CN1182876C (https=)
AU (1) AU770460B2 (https=)
CA (1) CA2329352A1 (https=)
NZ (1) NZ507498A (https=)
WO (1) WO1999055387A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217844B1 (en) * 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
US6458336B1 (en) * 2000-05-30 2002-10-01 The Trustees Of Columbia University In The City Of New York Detectably labeled porphyrin compound for identifying the sentinel lymph node
US20090252756A1 (en) * 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
WO2009036566A1 (en) * 2007-09-21 2009-03-26 Mount Sinai Hospital Methods for detecting abnormalities in breast tissue using aromatase inhibitors
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US4992421A (en) * 1988-04-19 1991-02-12 Abbott Laboratories Luteinizing hormone releasing hormone antagonist
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
US5340585A (en) * 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5371070A (en) * 1992-11-09 1994-12-06 The Salk Institute For Biological Studies Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins
US5824286A (en) * 1994-04-26 1998-10-20 The Medical College Of Hampton Roads Mammography method
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
DK0811382T3 (da) * 1996-06-03 2000-11-13 Hampton Roads Medical College Mammografisk fremgangsmåde
US6217844B1 (en) * 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists

Similar Documents

Publication Publication Date Title
CA2389235A1 (en) Controlled release hydrocodone formulations
EP0261429A1 (en) Penetration enhancement systems and the preparation thereof
IL96900A0 (en) Pharmaceutical composition containing naproxen
GEP20043315B (en) Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
JP2005515966A5 (https=)
ATE210424T1 (de) Verzoegerte freisetzung von peptiden aus pharmazeutischen zusammensetzungen
JP2007507538A5 (https=)
DE60327843D1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
RU2003100507A (ru) Фармацевтические композиции
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
CA2340898A1 (en) Compositions and methods for treating intracellular infections
MY124465A (en) Reduction of infarct volume using citicoline
WO2004050025A3 (en) Combination of ibuprofen and oxycodone for acute pain relief
JPH05507493A (ja) 哺乳動物の性腺刺激ホルモンレベルを調節するためのＧｎＲＨ拮抗薬とＧｎＲＨによる組合せ治療
IL135235A0 (en) Method and composition for preventing nephrotoxicity caused by cyclosporins and tacrolimus
JP2002512988A5 (https=)
RU98113920A (ru) Производные олигопептидов, содержащие d-алкилтриптофан и способные активировать высвобождение гормона роста
JP2002530353A5 (https=)
GB2328872B (en) Method for preparing pharmaceutical formulations
MY143571A (en) Eplerenone crystalline form
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
JP2001508769A (ja) アレンドロン酸塩及び胃排出を促進する薬剤を含有する医薬組成物
KR890014109A (ko) 의약제
CA2368352A1 (en) Method for treating neurodegeneration
CA2408920A1 (en) Methods for prevention of ulcers and improving physiological performance